Effectiveness of bevacizumab in first- and second-line treatment for metastatic colorectal cancer: ITACa randomized trial

BACKGROUND: Cancer trials involving multiple treatment lines substantially increase our understanding of therapeutic strategies. However, even when the primary end-point of these studies is progression-free survival (PFS), their statistical analysis usually focuses on each line separately, or does n...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Ther Adv Med Oncol
Egile Nagusiak: Petracci, Elisabetta, Scarpi, Emanuela, Passardi, Alessandro, Biggeri, Annibale, Milandri, Carlo, Vecchia, Stefano, Gelsomino, Fabio, Tassinari, Davide, Tamberi, Stefano, Bernardini, Ilaria, Accettura, Caterina, Frassineti, Giovanni Luca, Amadori, Dino, Nanni, Oriana
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: SAGE Publications 2020
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7378711/
https://ncbi.nlm.nih.gov/pubmed/32754229
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835920937427
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak